000			02001cam a2200313 4500500
005			20250121110911.0
041			_afre
042			_adc
100	1	0	_aTapia, Géraldine _eauthor
700	1	0	_a Perez-Dandieu, Béatrice _eauthor
245	0	0	_aIntegrating schema therapy into the treatment of a substance use disorder comorbid with post-traumatic stress disorder
260			_c2022.
500			_a1
520			_aPTSD often coexists with other psychiatric disorders, including SUD (Simpson, Rise, Browne, Lehavot, & Kaysen, 2019). This comorbidity often complicates the management of these disorders especially as the concurrent onset of one increases the severity of the other (Stewart, Pihl, Conrod, & Dongier, 1998). To date, the few studies examining EMDR in comorbid SUD/PTSD have demonstrated its effectiveness on post-traumatic symptoms but more rarely on addictive symptoms (Tapia, 2019). This article defends the idea that Jeffrey Young’s schema therapy (Young, 1994) would be highly indicated to treat patients with this comorbidity. The aim of this article is therefore to demonstrate the interest of using an integrative therapeutic protocol that would combine schema therapy and EMDR tools among patients with comorbid SUD/PTSD. While waiting for the emergence of validated therapeutic recommendations for this population, we attempted to propose some clinical practice recommendations based on existing scientific data.
690			_atreatment
690			_asubstance use disorder
690			_apost-traumatic stress disorder
690			_aschema therapy
690			_aEMDR
690			_acomorbidity
690			_atreatment
690			_asubstance use disorder
690			_apost-traumatic stress disorder
690			_aschema therapy
690			_aEMDR
690			_acomorbidity
786	0		_nPsychotropes | 28 | 3 | 2022-12-22 | p. 57-86 | 1245-2092
856	4	1	_uhttps://shs.cairn.info/journal-psychotropes-2022-3-page-57?lang=en&redirect-ssocas=7080
999			_c538606 _d538606